Sign In

Thomas Luby

Director, Innovation at Texas Medical Center

Dr. Thomas Luby is a highly accomplished professional with a strong background in biology and immunology.

He obtained his B.S. in Biology from the State University of New York at Plattsburgh and further pursued his Ph.D. in Immunology at Tufts University.

Dr. Luby has held various key positions in prestigious organizations, showcasing his expertise and leadership skills.

His professional journey includes roles such as Member Board of Directors at March Biosciences, Briteseed, LLC, and Noninvasix.

He has also served as Director at TMC Innovation and TMC Venture Fund at Texas Medical Center, highlighting his strategic acumen in the healthcare sector.

With a strong background in the pharmaceutical industry, Dr. Luby has held significant positions at Johnson & Johnson, Shire HGT, Eisai Research Institute, MGI Pharma, and Zycos, Inc.

His roles at Johnson & Johnson include Head of JLABS Texas, Sr. Director of New Ventures, and Board Observer at ArmaGen, Inc., reflecting his versatility and broad experience.

Dr. Luby's expertise extends to therapeutic areas such as Immuno-Oncology, where he has served as Therapeutic Area Head.

His contributions to the field of immunology and biology are evident through his tenure as Group Leader of Immunology at Zycos, Inc., showcasing his deep domain knowledge.

Overall, Dr. Thomas Luby is a seasoned professional with a rich history of leadership roles within the pharmaceutical and healthcare industries, making him a valuable asset to any organization.

Thomas Luby
Add to my network

Location

Houston, Texas, United States